Western University

Scholarship@Western
Paediatrics Publications

Paediatrics Department

1-1-2011

Chest compressions and epinephrine during resuscitation of
infants born at the border of viability: Yes, no or maybe?
Gregory P. Moore
Thierry Daboval
Kevin W. Coughlin

Follow this and additional works at: https://ir.lib.uwo.ca/paedpub
Part of the Pediatrics Commons

Narrative review

Chest compressions and epinephrine during
resuscitation of infants born at the border of viability:
Yes, no or maybe?
Gregory P Moore MD FRCPC FAAP1,2,3, Thierry Daboval MD FRCPC1,2,3, Kevin W Coughlin MD FRCPC MHSc4,5

Neonatology, in large part due to its population of babies born at the
edge of viability, is rife with bioethical issues. This unique population
is at high risk of mortality and considerable neurodevelopmental
morbidity. One contentious, ongoing debate concerns whether these
extremely low birth weight infants born at the border of viability
should, if required by the Neonatal Resuscitation Program guide
lines, receive chest compressions and epinephrine as part of their
delivery room resuscitation. The present article, through a case
presentation and discussion based on the ethical framework of prin
ciplism, provides readers with a thoughtful approach to the contro
versial issue of the provision of chest compressions and epinephrine
as part of resuscitation for extremely low birth weight infants born at
the border of viability.
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N

eonatology provides multiple profound and interesting cases to
examine bioethical issues and principles. Extremely low birth
weight (ELBW) premature infants, defined as those with a birth
weight of lower than 1000 g, comprise a significant proportion of the
patient population. Some of these infants are born at less than
25 weeks’ gestation – a gestational age that is generally considered to
be at the border of viability. When born in this gestational age range,
at least 50% of infants will either die or have considerable neuro
developmental impairment. The decision regarding whether to resus
citate such babies is an ongoing debate. Many centres do resuscitate
these infants, which raises a secondary question: if the medical team
provides respiratory resuscitation (including intubation), should they
give chest compressions (CC) and epinephrine when it is required, as
per the Neonatal Resuscitation Program (NRP) guidelines? The
present review will, through a case presentation and discussion based
around the ethical framework of principlism, provide readers with a
thoughtful approach to the controversial issue of the provision of CC
and epinephrine as part of resuscitation for ELBW infants born at the
border of viability. Principlism was chosen as the bioethical frame
work with which to examine this question because most clinicians are
more familiar with it than other ethical frameworks.

CASE PRESENTATION

Mrs Dawn (see Disclaimer), a 23yearold woman in her first preg
nancy, presented to her local medical centre at a gestation of

L’administration de compressions thoraciques
et d’adrénaline pendant la réanimation chez les
nourrissons nés à la limite de la viabilité :
Oui, non ou peut-être?
La néonatologie, en grande partie à cause de sa population de bébés
nés à la limite de la viabilité, regorge d’enjeux bioéthiques. Cette
population unique est très vulnérable à la mortalité et à une morbidité
neurodéveloppementale considérable. Une question litigieuse et continue
consiste à se demander si ces nourrissons d’extrême petit poids de
naissance nés à la limite de la viabilité devraient, si les lignes directrices du
Programme de réanimation néonatale l’indiquent, recevoir des compressions
thoraciques et de l’adrénaline dans le cadre de leur réanimation en salle
d’accouchement. Au moyen d’une présentation de cas et d’un exposé
fondé sur la structure éthique du principlisme, le présent article offre
au lecteur une démarche réfléchie à l’égard de la question controversée
d’administrer des compressions thoraciques et de l’adrénaline dans le cadre
de la réanimation de nourrissons d’extrême petit poids de naissance nés à
la limite de la viabilité.

24 weeks plus one day with premature rupture of membranes.
Given the concerns about possible premature delivery, Mrs Dawn
was given a dose of antenatal steroids and transferred by air to the
nearest tertiary care centre.
The paediatrics team consulted with Mrs Dawn and her husband;
they were told that the statistics reported a 65% chance of death or
significant neurodevelopmental impairment if the baby survived
after being born at this gestational age (1). Given these statistics, the
parents were informed of the treatment options, which included
either an active attempt to resuscitate their baby or the provision of
palliative care with the understanding that they would be able to
hold their baby until it passed away in a short period of time.
Resuscitation was described as only respiratory support including
intubation and ventilation. There was no offer of CC or epinephrine
during resuscitation at this gestational age because it was considered
futile by the neonatal team. The parents decided that they would
provide palliative care.
At a gestational age of 24 weeks plus six days, the paediatrics
team came to revisit the issues relating to a baby being born at
25 weeks’ gestation. The statistics now suggested a 40% chance of
death or significant neurodevelopmental impairment if the baby
was born at this gestational age (1). The parents were told that the
standard of care for babies born at this gestational age and beyond
was full resuscitation. The parents were surprised by this informa
tion and stated that they had been given the impression that
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DISCUSSION

If delivery room resuscitation is provided for an ELBW infant at
the edge of viability, should CC and epinephrine be a mandatory
part of the resuscitation as outlined in the NRP guidelines? As
with many ethical issues, there is no simple or universally applic
able answer to this question. Insufficient research has been pub
lished to answer the question. However, by considering key
bioethical principles in conjunction with an examination of the
practical issues surrounding administration of CC and epineph
rine, as well as a review of the more recently published clinical
outcomes, we hope to provide health care practitioners (HCPs)
with insight into the controversy surrounding the provision of
CC and epinephrine to ELBW infants. We propose a solution to
this controversy based on ethical considerations.
The NRP guidelines (2) were initially published before the
routine survival of ELBW infants (3). Although at first considera
tion these infants may appear to simply be ‘miniature’ versions of
fullterm infants, they are anything but; they are a unique popula
tion with dramatically heightened risks of death and severe mor
bidities (4). These risks are most significant for infants born at the
edge of viability. Appropriate delivery room resuscitation contrib
utes significantly to improving these outcomes, as demonstrated by
the decreased death and morbidity rates observed with ELBW
infants born in tertiary care hospitals compared with those born
elsewhere (5). Given the risks associated with the resuscitation of
ELBW infants, it is recognized that there will be differences in how
and when NRP guidelines are used. What benefits a fullterm neo
nate by promoting survival with little chance of neurodevelop
mental impairment, may actually result in harm to an ELBW
infant (eg, survival with severe neurodevelopmental disability [6]).
There have been discussions about modifying the NRP guidelines
surrounding the use of CC and/or epinephrine for ELBW babies,
but the amount and/or quality of evidence supporting any modifi
cations in this population is underwhelming. The risktobenefit
ratio for these interventions in the resuscitation of ELBW infants
remains a debatable subject.
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The absence of clear data suggesting usefulness in conjunction
with the presence of possible harms creates a situation of equi
poise. These are situations in which HCPs often experience moral
distress surrounding decision making. If these situations are not
adequately resolved with thoughtful process, the HCPs can be left
with significant residue. It is in times such as these that ethical
frameworks help us make a wellconsidered decision about an
appropriate course of treatment. The ethical framework of princi
plism, as coined by Beauchamp and Childress (7), is one with
which most HCPs are familiar. Its use in the present review will
help HCPs consider their approach to the provision of CC and/or
epinephrine to ELBW infants born at the edge of viability.
Principlism’s constituent parts include respect for autonomy, non
maleficence, beneficence and justice (7).
Beneficence is defined as “a group of norms pertaining to reliev
ing, lessening, or preventing harm and providing benefits and
balancing benefits against risks and costs” (7). If an intervention
provides no benefit, it should not even be considered; if there are
benefits, they must be weighed against the risks before instituting
the intervention. Given that the vast majority of neonates, includ
ing premature ones, with a heart rate of less than 60 beats/min
respond favourably to 30 s of effective positive pressure ventilation
(PPV) (2,8), its beneficence is obvious. Unfortunately, effective
PPV is not always easily accomplished in ELBW infants due to
increased difficulties with suctioning, positioning, equipment
selection (8,9), intubation (10) and positive endexpiratory pres
sure use (8,11). Even when PPV is achieved, the traditional chest
rise may not be observed despite adequate tidal volumes (12).
Given these difficulties with establishing and assessing effective
PPV and, moreover, the fact that even effective PPV will not
uniformly improve the heart rate, some ELBW infants will remain
bradycardic for more than 30 s. If CC are initiated as per NRP
guidelines, this intervention may be life saving by sustaining car
diac output and circulating blood to the vital organs (2). Animal
models of adult cardiac arrest suggest that CC alone provides bet
ter neurological outcomes than CC and PPV (13). Although the
applicability of this and other data (14) to neonates can certainly
be questioned, it does suggest that CC support cardiac output. At
the same time, CC may cause harm by hindering the provision of
what the baby needs most – continued, effective PPV. If CC fail to
improve the neonate’s clinical condition, the addition of epineph
rine may result in the return of spontaneous circulation (based
on animal studies) due, in part, to its enhancement of the coron
ary artery perfusion pressure (15). The actual benefit to human
patients is more difficult to surmise due to the understandable
ethical barriers to prospective or laboratorybased human research
on the subject.
The principle of nonmaleficence is defined as “[the] norm of
avoiding the causation of harm” (7). Due to the absence of a clear
benefit with the use of CC and epinephrine, the principle of non
maleficence must be considered. It has been hypothesized that CC
causes atelectasis (16) and may, therefore, have a negative impact
on the establishment of effective PPV. In addition, CC may cause
rib fractures and pneumothoracies during aggressive resuscitative
attempts (1719). The few studies investigating these outcomes are
limited by small sample sizes and primarily rely on autopsy speci
mens for diagnosis. The results are equivocal but do not suggest an
increase in severe complications. The appropriate use and dosing of
epinephrine remain unclear and largely unstudied, and are primarily
extrapolated from the adult literature. The possibility of direct
harmful effects, such as intraventricular hemorrhage and decreased
survival with high doses, due to this drug exists (15). Epinephrine,
when given for persistent bradycardia despite CC and PPV, may
Paediatr Child Health Vol 16 No 2 February 2011
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palliation was still an option and they had made the decision to
wait until 26 weeks’ gestation to consider resuscitation.
The neonatal consultant then became involved in the discus
sion. The use of CC and epinephrine was mentioned as something
that could be provided but, if required, was generally a bad sign for
the baby’s outcome. The parents believed that they had made the
right decision at 24 weeks and that it should remain the same at
25 weeks, even in the face of improved statistics.
After much discussion, it was decided that the current decision
for palliation would stand because the gestational age of the fetus
was still 24 weeks plus six days. The discussion was to be continued
the next morning with the parents, the consultant, the medical
director of neonatal services and the hospital legal counsel.
That evening, Mrs Dawn experienced sudden cramping and
then saw that the baby’s foot was presenting. She and her husband
began to fluctuate between saying “Do everything and help the
baby”, “No, this isn’t supposed to happen, the baby’s too young, we
don’t want the baby resuscitated”, and “We don’t know what to
do”. In the face of parental indecision, the neonatal fellow in
attendance said the paediatric team would initiate resuscitation if
the baby was born with a heart rate. No discussion occurred about
whether “everything” included CC and epinephrine.
Sadly, the baby died before delivery due to prolonged cervical
entrapment of the head; a decision about resuscitation and the use
of CC or epinephrine was, therefore, not required. It is, neverthe
less, an important question to consider.

Chest compressions and epinephrine for ELBW infants
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The difference between parental and HCP viewpoints must be
acknowledged and discussed (31,32). Parents should be informed
by their HCP about all reasonable options for resuscitation includ
ing palliative care, ventilatory support, CC and epinephrine. In
the absence of obvious incapacity or clear harms, parental deci
sions should be respected.
Justice is defined as “a group of [normative values] for fairly
distributing benefits, risks and costs” (7). In the context of this
discussion, it can be summarized as the ethical requirement to treat
equal cases equally. If CC and epinephrine are offered to larger,
more mature babies with the same benefits, limitations and out
comes, it should be offered to infants at the extremes of prematur
ity. In addition, on a systemic level, if parents are offered a choice
about the provision of CC and epinephrine during resuscitation at
some centres, then parents giving birth in similar circumstances at
other centres should have the same options. Invoking this princi
ple of distributive justice ensures these cases are treated equiva
lently on a national and international level.

CLINICAL IMPLICATIONS

Is there presently a clear answer to the original question about the
appropriateness of using CC and epinephrine in the delivery room
resuscitation of infants at the extremes of prematurity? The medical
literature acknowledges the beneficence of resuscitation, and the
lack of specific and predictable harms caused by the use of CC and
epinephrine in this population. It confirms that infants at the
extremes of prematurity requiring these measures can survive with a
neurodevelopmental outcome comparable with agematched sur
vivors who do not require CC or epinephrine. Tertiary care neonatal
units in Canada offer parents resuscitation of their infants when
born at the extremes of prematurity. Analysis of this clinical situa
tion using the ethical framework of principlism strongly supports
offering CC and epinephrine as part of the routine resuscitation
plan for infants born at the extremes of prematurity.

FUTURE DIRECTIONS

A survey of Canadian (and international) neonatologists’ practi
ces regarding this controversial issue would be of great value, and
increase our knowledge base and understanding of the current use
of CC and epinephrine; such a survey is currently in early develop
ment, with distribution planned in the coming months.
DISCLAIMER: This case is not based on any one specific reallife
case and, as such, there is no identifying patient information.
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help increase the heart rate and improve cardiac output but, when it
is given via an endotracheal tube (common for first dose[s] in an
extensive resuscitation), the appropriate dose and its efficacy are
uncertain (20). It has the potential to obstruct the airway with
resulting lung collapse and transient loss of effective PPV. The risk
of accidental extubation may also increase due to endotracheal tube
manipulations, further compromising PPV (21). These concerns
exist for all neonates requiring extensive resuscitation and are,
therefore, not unique to the ELBW population.
The practical issues of delivering CC and epinephrine during
the resuscitation of ELBW infants and the exploration of benefits
versus harms, as outlined above, lead one to consider the effective
ness or, alternatively, the futility of providing CC and epinephrine
in this unique population. Futility of medical care was recently
reviewed (22). If a treatment benefits neither the physical nor
overall wellbeing of a patient, then the treatment, even if desired
by the patient or family, is futile and not medically indicated.
Several studies (2325) since 1999, each retrospective and small
in sample size, have investigated the outcomes of ELBW infants
who received CC and/or epinephrine in the delivery room. Studies
before 1999 generally supported the argument that outcomes were
worse for preterm infants who required CC and/or epinephrine.
While no study has exclusively evaluated infants born at the
extremes of viability (ie, less than 25 weeks), several focused on
ELBW infants and can provide useful information. SanchezTorres
et al (23) reported no difference in survival and nonneurological
morbidity between infants weighing less than 996 g who did and did
not receive CC, but those who received CC had three times
(P<0.01) the rate of general neurological morbidity (defined as a
combined outcome of grade III intraventricular hemorrhages, peri
ventricular hemorrhagic infarctions and/or periventricular cystic
leukomalacia). While important shortterm outcomes, these surro
gate outcomes do not uniformly predict longterm outcomes. Finer
et al (24) noted an increase in mortality and morbidity in infants
weighing less than 1000 g receiving CC compared with controls, but
pointed out that even in the CC group, the majority survived and
showed no evidence of severe intraventricular hemorrhages. In
another article, Finer et al (25) discovered that infants weighing less
than 750 g who received CC or CC and epinephrine could have an
intact survival as assessed by neurodevelopmental outcomes at more
than nine months. They noted that the intact survival rate in the
group that received CC or CC and epinephrine was not significantly
different from the matched control group who did not require CC.
Jankov et al (26) also reported a case series in which 16 infants
weighing less than 750 g received CC or CC and epinephrine, and
noted that eight of the nine survivors were free of significant
neurodevelopmental disabilities at two years of age or older.
Although there are definite limitations to the studies cited and
it is clear more research is required, the literature suggests that
infants at the edge of viability who receive CC and/or epinephrine
can survive and have comparable longterm outcomes to age
matched controls who did not require these measures. Given the
potential benefits and lack of definitive harms, this treatment does
not satisfy the criteria for medical futility. The remaining ethical
principles of respect for autonomy and justice must be considered.
In western medical culture, respect for patient autonomy (in
this case, parental authority) holds significant importance. Our
legal and ethical obligations are to ensure that parents know the
aforementioned information when deciding on a resuscitation
plan for their ELBW infant. Emerging research has explored differ
ent types of physicianpatient relationships (27,28) and parental
decision making (29,30). The importance of parental participation
in the decisionmaking process was universally identified.
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